Morning Advantage: Can Markets Cure Cancer?
Harvard Business Review
OCTOBER 17, 2012
"With proper financial engineering, I am absolutely convinced we can solve cancer," MIT professor Andrew Lo says. One cancer trial costs about $200 million and has fairly low odds of success. But if you do lots of research and conduct many trials at the same time, your odds of success are greater. So how do you pay for it?
8 
Let's personalize your content